Mulgrew Alan T, Fox Nurit, Ayas Najib T, Ryan C Frank
University of British Columbia and Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.
Ann Intern Med. 2007 Feb 6;146(3):157-66. doi: 10.7326/0003-4819-146-3-200702060-00004.
Polysomnography (PSG), despite limited availability and high cost, is currently recommended for diagnosis of obstructive sleep apnea and titration of effective continuous positive airway pressure (CPAP).
To test the utility of a diagnostic algorithm in conjunction with ambulatory CPAP titration in initial management of obstructive sleep apnea.
A randomized, controlled, open-label trial that compared standard PSG with ambulatory CPAP titration in high-risk patients identified by a diagnostic algorithm.
A tertiary referral sleep disorders program in Vancouver, British Columbia, Canada.
68 patients with a high pretest probability of moderate to severe obstructive sleep apnea (apnea-hypopnea index [AHI] >15 episodes/h) identified by sequential application of the Epworth Sleepiness Scale (ESS) score, Sleep Apnea Clinical Score, and overnight oximetry.
Patients were randomly assigned to PSG or ambulatory titration by using a combination of auto-CPAP and overnight oximetry. They were observed for 3 months.
Apnea-hypopnea index on CPAP, ESS score, quality of life, and CPAP adherence.
The PSG and ambulatory groups had similar median BMI (38 kg/m2), age (55 years), ESS score (14 points), and respiratory disturbance index (31 episodes of respiratory disturbance/h). Each episode is determined by a computer algorithm based on analysis of oxygen saturation measured by pulse oximetry. After 3 months, there were no differences in the primary outcome, AHI on CPAP (median, 3.2 vs. 2.5; difference, 0.8/h [95% CI, -0.9 to 2.3]) (P = 0.31), between the PSG and ambulatory groups, or in the secondary outcomes, ESS score, Sleep Apnea Quality of Life Index, and CPAP. Adherence to CPAP therapy was better in the ambulatory group than in the PSG group (median, 5.4 vs. 6.0; difference, -1.12 h/night [CI, -2.0 to 0.2]) (P = 0.021).
In the initial management of patients with a high probability of obstructive sleep apnea, PSG confers no advantage over the ambulatory approach in terms of diagnosis and CPAP titration. The ambulatory approach may improve adherence to treatment. When access to PSG is inadequate, the ambulatory approach can be used to expedite management of patients most in need of treatment.
多导睡眠图(PSG)尽管可用性有限且成本高昂,但目前仍被推荐用于阻塞性睡眠呼吸暂停的诊断以及有效持续气道正压通气(CPAP)的滴定。
测试一种诊断算法结合动态CPAP滴定在阻塞性睡眠呼吸暂停初始管理中的效用。
一项随机、对照、开放标签试验,比较了通过诊断算法识别出的高危患者中标准PSG与动态CPAP滴定。
加拿大不列颠哥伦比亚省温哥华的一个三级转诊睡眠障碍项目。
68例经Epworth嗜睡量表(ESS)评分、睡眠呼吸暂停临床评分和夜间血氧饱和度测定依次应用后,中度至重度阻塞性睡眠呼吸暂停(呼吸暂停低通气指数[AHI]>15次/小时)预测试概率较高的患者。
患者通过自动CPAP和夜间血氧饱和度测定的组合被随机分配至PSG或动态滴定组。对他们进行了3个月的观察。
CPAP上的呼吸暂停低通气指数、ESS评分、生活质量和CPAP依从性。
PSG组和动态滴定组的中位体重指数(38kg/m²)、年龄(55岁)、ESS评分(14分)和呼吸紊乱指数(31次呼吸紊乱/小时)相似。每一次发作由基于脉搏血氧饱和度测定的氧饱和度分析的计算机算法确定。3个月后,PSG组和动态滴定组在主要结局CPAP上的AHI(中位数,3.2对2.5;差异,0.8/小时[95%CI,-0.9至2.3])(P = 0.31)以及次要结局ESS评分、睡眠呼吸暂停生活质量指数和CPAP方面均无差异。动态滴定组对CPAP治疗的依从性优于PSG组(中位数,5.4对6.0;差异,-1.12小时/晚[CI,-2.0至0.2])(P = 0.021)。
在阻塞性睡眠呼吸暂停高概率患者的初始管理中,PSG在诊断和CPAP滴定方面并不比动态方法更具优势。动态方法可能会提高治疗依从性。当PSG的可及性不足时,动态方法可用于加快对最需要治疗的患者的管理。